XOMAP FY 2023 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-21.1% YoY

Gross Profit

$5M97.0% margin

Operating Income

-$42M-879.5% margin

Net Income

-$41M-858.2% margin

EPS (Diluted)

$-4.04

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$234M

Total Liabilities

$146M

Stockholders' Equity

$89M

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$6M	-21.1%
Gross Profit	$5M	$6M	-19.8%
Operating Income	-$42M	-$17M	-140.3%
Net Income	-$41M	-$17M	-138.7%